Organon launches two denosumab biosimilars in Canada
Go back to Organon launches two denosumab biosimilars in Canada| (NYSE: OGN) | Delayed: 13.57 +0.05 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.52 | 52 Week High | $8.00 | |||
| Open | $13.51 | 52 Week Low | $8.00 | |||
| Day High | $13.57 | P/E | N/A | |||
| Day Low | $13.51 | EPS | $0.00 | |||
| Volume | 1,623,491 | |||||
